Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

For Industry and Sponsors

Our Key Statistics

  • We treat 200+ patients per year
  • We currently have 90 active trials
  • We have a referral base of ~20M population (West and East Midlands, South West and South Central England)
  • Our team of ~50 staff includes trial administrators, research nurses, clinical staff, laboratory staff and quality assurance

Prior and ongoing first in man studies with (not exclusive list):

  • Immunocore, Repimmune, Janssen, Vertex, Bayer, Rigontec, Regeneron, Carrick Therapeutics, Roche Genentech, BioInvent, Nucana, Boehringer Ingelheim, RS Oncology, Hummingbird Bioscience, Mythic Therapeutics, Exscientia, Novartis, AZ, Clovis, Pfizer, Millenium, Roche, Vertex, Bayer, Rigontec, Regeneron, CytomX
In this section